Table 2. Severe adverse events according to rapid drug desensitization.
Severe adverse events | RDD group (n = 104) | Control group (n = 271) |
---|---|---|
Death | 1 (1.0) | 0 (0.0) |
Cardiac disorders | 0 (0.0) | 1 (0.4) |
Gastrointestinal disorders (except nausea) | 0 (0.0) | 8 (3.0) |
Infection and infestations | 6 (5.8) | 11 (4.1) |
Injury, poisoning and procedural complications | 0 (0.0) | 1 (0.4) |
Nausea and nutrition disorders | 2 (1.9) | 8 (3.0) |
General disorders | 0 (0.0) | 3 (1.1) |
Respiratory, thoracic and mediastinal disorders | 0 (0.0) | 1 (0.4) |
Skin and subcutaneous tissue disorders | 0 (0.0) | 1 (0.4) |
Total | 8 (7.7) | 34 (12.5) |
RDD, rapid drug desensitization.